Literature DB >> 1942249

Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis.

P E Tam1, A M Schmidt, S R Ytterberg, R P Messner.   

Abstract

Mice infected with coxsackievirus B1 (CVB1) develop a chronic hindquarter muscle weakness which resembles human polymyositis. In this study, we used in situ hybridization to screen for persistent viral RNA in hamstring and quadriceps muscles from mice that displayed various degrees of clinical weakness. At 28 to 31 days postinfection, when chronic myositis is well developed but infectious virus can no longer be recovered, persistent CVB1 RNA was found in hindquarter skeletal muscle of all 12 infected animals examined. Persistent CVB1 showed a multifocal distribution within muscle and was associated with three different histopathology patterns (HPPs). These three HPPs (HPP-1, HPP-2, and HPP-3) represent potentially different stages in the mechanism of persistence. They are based on the pattern of grains, the location of hybridization signal within the muscle, and the accompanying histopathology. In HPP-1, virus persisted in nonnecrotic muscle fibers and was not directly associated with foci of inflammatory cells. HPP-2 consisted of virus contained within necrotic myocytes that were surrounded by inflammatory cells. HPP-3 was rare and showed virus inside infiltrating mononuclear cells in a region where muscle tissue had been extensively destroyed. Persistent CVB1 occurred more frequently in severely diseased animals and in tissue sections displaying intense inflammation. Moreover, HPP-2 showed a stronger association with tissue inflammation and hindquarter weakness than did HPP-1. These data demonstrate that CVB1 persists in skeletal muscle for at least 28 to 31 days postinfection and support the concept that this persistence plays a role in the development of murine polymyositis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1942249      PMCID: PMC250734     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Comparison of genomic homologies in the coxsackievirus B group by use of cDNA:RNA dot-blot hybridization.

Authors:  S Tracy
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

2.  Persistence of Coxsackie B1 virus in Balb/C mice.

Authors:  E V Bocharov; O V Shalaurova
Journal:  Acta Virol       Date:  1984-07       Impact factor: 1.162

3.  Coxsackie B neutralisation titres in polymyositis/dermatomyositis.

Authors:  R L Travers; G R Hughes; G Cambridge; J R Sewell
Journal:  Lancet       Date:  1977-06-11       Impact factor: 79.321

4.  Detection of enteroviruses by spot hybridization.

Authors:  T Hyypiä; P Stålhandske; R Vainionpää; U Pettersson
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

5.  Membrane-bound virions of coxsackievirus B4: cellular localization, analysis of the genomic RNA, genome-linked protein, and effect on host macromolecular synthesis.

Authors:  N K Chatterjee; C Nejman
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

6.  Selective polymyositis inducted by coxsackievirus B1 in mice.

Authors:  C G Ray; L L Minnich; P C Johnson
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

7.  Evidence for a novel picornavirus in human dermatomyositis.

Authors:  N L Rosenberg; H A Rotbart; M J Abzug; S P Ringel; M J Levin
Journal:  Ann Neurol       Date:  1989-08       Impact factor: 10.422

8.  A murine model of polymyositis induced by coxsackievirus B1 (Tucson strain).

Authors:  S L Strongwater; K Dorovini-Zis; R D Ball; T J Schnitzer
Journal:  Arthritis Rheum       Date:  1984-04

9.  Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and +/nu mice.

Authors:  D P Schnurr; N J Schmidt
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

10.  Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells.

Authors:  R Kandolf; P H Hofschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

View more
  11 in total

Review 1.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 2.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

3.  Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution.

Authors:  P E Tam; R P Messner
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets.

Authors:  K Klingel; S Stephan; M Sauter; R Zell; B M McManus; B Bültmann; R Kandolf
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy.

Authors:  Patricia E Tam; Melissa L Weber-Sanders; Ronald P Messner
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  Polymyositis and dermatomyositis: no persistence of enterovirus or encephalomyocarditis virus RNA in muscle.

Authors:  P J Jongen; G J Zoll; M Beaumont; W J Melchers; L B van de Putte; J M Galama
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

7.  Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Stephanie Harkins; Daniel E Hassett; J Lindsay Whitton
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency.

Authors:  Ralph Feuer; Ignacio Mena; Robb R Pagarigan; Daniel E Hassett; J Lindsay Whitton
Journal:  Med Microbiol Immunol       Date:  2003-08-19       Impact factor: 3.402

9.  5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart.

Authors:  Nora M Chapman; Kyung-Soo Kim; Kristen M Drescher; Kuniyuki Oka; Steven Tracy
Journal:  Virology       Date:  2008-04-01       Impact factor: 3.616

10.  Interactions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1.

Authors:  Maribeth M Sandager; Jaime L Nugent; Wade L Schulz; Ronald P Messner; Patricia E Tam
Journal:  Virology       Date:  2007-11-26       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.